Puma Biotech (PBYI) Reports Q4 Loss of $1.23/Share

Puma Biotech (NYSE: PBYI) reported Q4 EPS of ($1.23), versus ($1.03) reported last year.

For earnings history and earnings-related data on Puma Biotech (PBYI) click here.

You May Also Be Interested In

• Delta Air Lines stock climbs on earnings beat and strong guidance
• AMD (AMD) PT Raised to $635 at Stifel as 'EPYC Server-CPU Franchise is an AI Winner'
• ONEOK Inc (OKE) PT Raised to $95 at Mizuho